Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Novel agents on the horizon for cancer therapy
Wen W. Ma,
Alex A. Adjei
Medical Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
283
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Novel agents on the horizon for cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Proto-Oncogene Proteins c-met
100%
HSP90 Heat-Shock Proteins
95%
Neoplasms
93%
Erlotinib Hydrochloride
91%
Sorafenib
89%
Bortezomib
88%
Trastuzumab
86%
src-Family Kinases
86%
Growth Factor Receptors
85%
Biotechnology
83%
Methyltransferases
80%
Bevacizumab
80%
Biological Factors
77%
Proteasome Endopeptidase Complex
75%
Tumor Microenvironment
75%
Ubiquitin
72%
Mitogen-Activated Protein Kinases
71%
Antineoplastic Agents
69%
ErbB Receptors
68%
Drug Development
68%
Integrins
68%
Endothelium
64%
Epigenomics
63%
Phosphotransferases
56%
Monoclonal Antibodies
52%
Insulin
49%
Therapeutics
47%
Technology
47%
Clinical Trials
47%
Quality of Life
46%
Membranes
43%
DNA
40%
Survival
40%
Pharmaceutical Preparations
29%
Proteins
26%